Founding Organizations:

Thank you to Madrigal for sponsoring this FAQ Video Module.

In this GHAPP FAQ Video Module, Corrie Berk, NP, Director of Hepatology and Transplant Outreach Programs at the Texas Liver Institute, explains the liver condition known as MASH, or metabolic dysfunction-associated steatohepatitis, which was previously referred to as NASH. She describes MASH as an inflammatory liver disease caused by excess fat buildup in the liver and its close connection to metabolic issues like obesity, type 2 diabetes, and dyslipidemia. Corrie also discusses the significance of the name change from NASH to MASH, highlighting the shift toward recognizing metabolic health as a key factor in managing the disease.